Global Peptide Therapeutics Market to Skyrocket: Estimated Growth at a CAGR of 10.8% to Reach USD 117.4 Billion by 2034: FMI NEWARK, Del, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is set to revolutionize modern medicine, with sales projected to surge from USD 42.1 billion in 2024 to an...

Peptide Therapeutics Market to Witness 5.94% CAGR by 2031 | SkyQuest Technology Westford, USA, Sept. 27, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Peptide Therapeutics Market will attain the value of USD 68.4 Billion by 2031, with a CAGR of 5.94% during the forecast...

Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc. NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...

Peptide Therapeutics Market Will Reach USD 43.26 Billion By 2024, Globally: Zion Market Research New York, NY, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type...

Peptide Therapeutics Market Value to Reach US$46.6 billion by the End of 2024: Transparency Market Research Albany – NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The global market for peptide therapeutics has been dominated by Teva, Novo Nordisk, Eli Lilly, and Sanofi, states Transparency Market Research (TMR)...